Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48.9M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
5.8M
-
Shares change
-
+539K
-
Total reported value, excl. options
-
$43.7M
-
Value change
-
+$3.93M
-
Number of buys
-
26
-
Number of sells
-
-9
-
Price
-
$7.54
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q2 2016
37 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2016.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.8M shares
of 48.9M outstanding shares and own 11.85% of the company stock.
Largest 10 shareholders include FMR LLC (2.67M shares), JPMORGAN CHASE & CO (1.58M shares), Lombard Odier Asset Management (USA) Corp (342K shares), BlackRock Fund Advisors (289K shares), VANGUARD GROUP INC (248K shares), Allianz Asset Management AG (119K shares), STATE STREET CORP (113K shares), MORGAN STANLEY (59.6K shares), BlackRock Institutional Trust Company, N.A. (55.5K shares), and GEODE CAPITAL MANAGEMENT, LLC (48.3K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.